Maui wildfire study finds toxic metals in residents' urine months later
A University of Hawaiʻi study of 1,400 adults links elevated metal levels to abnormal lung function up to 18 months after the 2023 Lāhainā fires.
Medicine & Biotech
Clinical AI, drug discovery, devices, and regulatory approvals.
Twin Doctors Return Home to Co-Lead Richmond Emergency Department
Identical twin physicians Travan and Travis Jasper have returned to their Richmond hometown to jointly lead Chippenham Hospital's emergency department.
Cataract Surgery Linked to Small Increase in Wet AMD Conversion
A large registry analysis finds a modest, time-limited association between cataract surgery and progression from dry to wet AMD, but experts caution it may reflect surveillance rather than causation.
Coalition Launches to Expand Direct Contracting, Lower Costs
The Association for Direct Care has launched a coalition aimed at expanding direct contracting to reduce healthcare costs.
FDA Approves Obinutuzumab for Idiopathic Nephrotic Syndrome
The first new treatment in 70 years for a rare kidney autoimmune disease offers an alternative to steroids for children and young adults.
Adicet's off-the-shelf CAR-T shows promise in lupus trial
Early data suggest an allogeneic gamma delta CAR-T therapy can drive lupus into remission without the severe side effects seen with personalized treatments.
HPV Vaccine Guidance May Shift to One Dose for Preteens
Experts are weighing whether a single HPV shot offers enough protection, which could simplify the adolescent vaccination schedule.
DreaMed's MODI App Gets FDA Clearance for Type 2 Insulin Dosing
The FDA cleared DreaMed's MODI app, which uses CGM data to recommend insulin doses for Type 2 diabetes patients on both basal and fast-acting injections.
UnitedHealth, Cigna, Centene Join Shared Provider Credentialing Network
A new national program lets providers submit credentialing information once for multiple major insurers, potentially cutting administrative overhead.
Glucosamine Use Tied to Faster Dementia Progression in Health-Record Study
A large retrospective analysis of UF Health records found glucosamine users with mild cognitive impairment were 25% more likely to progress to dementia, though causality remains unproven.
Medical Quotes of the Week: AI Integrity, Cancer Tests, and NIH Turmoil
A weekly roundup of expert quotes captures concerns about AI-generated research, the clinical value of early cancer tests, and the impact of federal health agency turmoil.
One CRISPR Dose Cut LDL Cholesterol by Half for a Year in Early Trial
A small Phase 1 trial found that a single infusion of the CRISPR therapy CTX310 produced durable reductions in LDL cholesterol and triglycerides in patients with hard-to-treat lipid disorders.
AI in Medicine Blurs Lines of Legal Liability
As AI takes on diagnosis and treatment planning, the question of who is legally responsible for errors becomes increasingly unclear.
MedTech Startups Fail When Business Lags Technology
A MedCity News analysis argues that early-stage medical device programs often stall because they prioritize technical feasibility over the business case.
Pediatric Rheumatology Treatments Exist, but Access Lags
Despite five decades of progress in pediatric rheumatology, many children still cannot access treatments that could prevent long-term damage.
Anesthesia Reimbursement Disparity: CRNAs Paid 85% of Physicians
An opinion piece argues that insurers' lower reimbursement for certified registered nurse anesthetists compared with physicians for the same services threatens access to care, especially in rural areas.
Mirum's Atebrioz Gains FDA Approval for Rare Bone Disorder FOP
The pill becomes the third FDA-approved treatment for fibrodysplasia ossificans progressiva, offering a new option for the ultra-rare condition.
Exercise After Cancer Improves Survival in Meta-Analysis
A meta-analysis of 21 randomized trials finds structured exercise after cancer treatment is associated with better overall and cancer-specific survival.